Feelnor 35 MR Tablet

Feelnor 35 MR Tablet সম্পর্কে

Feelnor 35 MR Tablet একটি ট্যাবলেট ঔষধ, যার জেনেরিক নাম Trimetazidine Dihydrochloride এবং শক্তি ৩৫ mg। Feelnor 35 MR প্রস্তুত করেছে Incepta Pharmaceuticals Ltd। Feelnor 35 MR-এর সাথে Trimetazidine Dihydrochloride-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।

Trimetazidine Dihydrochloride-এর ১৩টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Feelnor 20 mg Tablet-এর, প্রতি ইউনিট ৳ ৩।

Feelnor 35 MR Tablet কী?

Made by Incepta Pharmaceuticals Ltd., Feelnor 35 MR is a tablet whose active ingredient is Trimetazidine Dihydrochloride. Its active substance is Trimetazidine Dihydrochloride, which belongs to a group of metabolic anti-ischaemic and anti-anginal medicines. Feelnor 35 MR does not treat angina attacks or act as an initial treatment for unstable angina, and it is not a treatment for myocardial infarction. Whether it suits you is a decision for your doctor.

Feelnor 35 MR-এর ব্যবহার

Feelnor 35 MR is not a curative treatment for angina attacks, not an initial treatment for unstable angina pectoris, and not a treatment for myocardial infarction. Feelnor 35 MR is used in adults alongside other medicines for the symptomatic treatment of stable angina pectoris, when first-line anti-anginal therapies are not adequate or are not tolerated. Ask the doctor if you are unsure why it has been prescribed for you. Your doctor will decide if it is suitable for you.

Feelnor 35 MR কীভাবে ব্যবহার করবেন

Swallow the tablet as your doctor or pharmacist advises. Feelnor 35 MR is taken by mouth. Swallow the tablet with water. Take Feelnor 35 MR exactly as prescribed by your doctor. The doctor decides the dose and how long you take it, and may assess the benefit after a period of treatment. If you miss a dose or are unsure about anything, ask your doctor or pharmacist rather than adjusting the schedule on your own.

Feelnor 35 MR-এর পার্শ্বপ্রতিক্রিয়া

Do not decide on your own to stop or change the medicine; the doctor will advise what to do. Seek medical advice promptly if you develop a serious or unexpected reaction. If any side effect troubles you or does not settle, contact your doctor or pharmacist. Ask your doctor or pharmacist about anything you are worried about. Contact your doctor if you notice anything unusual after taking it.

সতর্কতা ও নিরাপত্তা

It is also contraindicated in anyone hypersensitive to the active substance or to any of the excipients. Feelnor 35 MR is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris, and it is not a treatment for myocardial infarction. Avoid it during pregnancy and breast-feeding. Tell your doctor if you are pregnant, planning pregnancy or breast-feeding, and ask a doctor first if you have kidney problems or movement symptoms.

সাধারণ প্রশ্ন

What does Feelnor 35 MR treat?

Feelnor 35 MR is not a curative treatment for angina attacks, not an initial treatment for unstable angina pectoris, and not a treatment for myocardial infarction. Feelnor 35 MR is used in adults alongside other medicines for the symptomatic treatment of stable angina pectoris, when first-line anti-anginal therapies are not adequate or are not tolerated.

How do I use Feelnor 35 MR correctly?

Swallow the tablet as your doctor or pharmacist advises. Feelnor 35 MR is taken by mouth.

Can Feelnor 35 MR cause side effects?

Do not decide on your own to stop or change the medicine; the doctor will advise what to do. Seek medical advice promptly if you develop a serious or unexpected reaction.

Can I use Feelnor 35 MR in pregnancy or while breastfeeding?

It is also contraindicated in anyone hypersensitive to the active substance or to any of the excipients. Feelnor 35 MR is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris, and it is not a treatment for myocardial infarction.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Trimetazidine Dihydrochloride is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Trimetazidine Dihydrochloride is the first 3- keto acyl CoA thiolase inhibitor (KAT), a metabolic anti-ischemic agent with proven benefits for all coronary patients. Trimetazidine Dihydrochloride inhibits fatty acid pathway by inhibiting 3-keto acyl CoA thiolase enzyme and transfers oxygen to glucose pathway. Since glucose pathway is more efficient in producing energy, the same oxygen produces more energy and makes the heart more active. Moreover, the aerobic oxidation of glucose stops production of lactic acid, which prevents angina pectoris.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

The recommended dose of Trimetazidine is 35 mg twice daily or 20 mg tablet thrice daily during meals. The benefit of the treatment should be assessed after three months and Trimetazidine should be discontinued if there is no treatment response.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

No drug interaction so far has been reported. In particular, no interaction has been reported with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents or digitalis preparation.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Trimetazidine is contraindicated in patients who have hypersensitivity to the active substance or to any of the excipients. It is also is contraindicated in patients with Parkinson’s disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Trimetazidine is safe and well tolerated. The Common side effects associated with Trimetazidine are dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria and asthenia

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

There is no data on the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine during pregnancy. It is unknown whether Trimetazidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine should not be used during breast-feeding.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Trimetazidine is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris. It is also not a treatment for myocardial infarction.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Keep in a dry place away from light and heat. Keep out of the reach of children.

বিকল্প ব্র্যান্ড: Trimetazidine Dihydrochloride

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।